Truist initiated coverage of Exzeo (XZO) with a Buy rating and $25 price target The firm believes the company offers one of the more compelling combinations of growth, profit and free cash flow margin potential in the insurance space. The company’s value proposition has been validated by the results it has achieved with HCI, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XZO:
- Exzeo initiated with an Outperform at William Blair
- Exzeo Group, Inc.: Strong Buy Rating Due to Market Position and Growth Potential in Homeowners Insurance
- Exzeo initiated with an Outperform at Citizens JMP
- Opening Day: DNA test maker BillionToOne raises $314M in IPO
- HCI Group price target raised to $234 from $190 at Truist